/Dearborn Partners Raised Position in Gilead Sciences (GILD); Community Bank Decreased Its Position in Intl Business Machines (IBM) by $441,048 (via Qpute.com)
Gilead Sciences, Inc. (NASDAQ:GILD) Logo

Dearborn Partners Raised Position in Gilead Sciences (GILD); Community Bank Decreased Its Position in Intl Business Machines (IBM) by $441,048 (via Qpute.com)


Gilead Sciences, Inc. (NASDAQ:GILD) Logo

Community Bank decreased its stake in Intl Business Machines Corp (IBM) by 2.4% based on its latest 2019Q1 regulatory filing with the SEC. Community Bank sold 3,128 shares as the company’s stock declined 2.27% while stock markets rallied. The institutional investor held 127,118 shares of the computer manufacturing company at the end of 2019Q1, valued at $17.94 million, down from 130,246 at the end of the previous reported quarter. Community Bank who had been investing in Intl Business Machines Corp for a number of months, seems to be less bullish one the $123.11B market cap company. The stock increased 1.29% or $1.77 during the last trading session, reaching $138.85. About 2.80 million shares traded. International Business Machines Corporation (NYSE:IBM) has declined 6.86% since June 21, 2018 and is downtrending. It has underperformed by 11.29% the S&P500. Some Historical IBM News: 27/03/2018 – Direct Access to IBM Cloud Services Now Available at lnterxion Data Centres Across Europe via Cloud Connect; 17/04/2018 – IBM Earnings: There Are a Lot of Moving Parts Here — Barron’s Blog; 24/04/2018 – REG-lntnl Bus. Mach IBM Board Approves Increase in Quarterly Cash Dividend for the 23rd Consecutive Year; 20/03/2018 – Zerto Partners with IBM to Provide Data Protection for IBM’s Resiliency Orchestration DRaaS Solution; 02/04/2018 – Flashpoint Accelerates Channel and Strategic Partner Initiatives; Appoints Former IBM Executive Jeff Seifert as Global Channel Chief; 18/04/2018 – Holt Joins Maersk And IBM Global Shipping Platform To Boost Productivity At Packer Avenue Marine Terminal; 30/03/2018 – IBM sees quantum computing going mainstream within five years; 17/04/2018 – IBM 1Q OPERATING EPS $2.45, EST. $2.42; AFFIRMS YEAR VIEWS; 06/03/2018 – PacketFabric Offers Connectivity to IBM Cloud; 13/04/2018 – MICROSOFT, IBM, DELL, HPE ARE SAID TO BE INVOLVED IN INITIATIVE

Dearborn Partners Llc increased its stake in Gilead Sciences Incorporated (GILD) by 6.57% based on its latest 2019Q1 regulatory filing with the SEC. Dearborn Partners Llc bought 16,984 shares as the company’s stock declined 0.97% while stock markets rallied. The institutional investor held 275,567 shares of the health care company at the end of 2019Q1, valued at $17.92 million, up from 258,583 at the end of the previous reported quarter. Dearborn Partners Llc who had been investing in Gilead Sciences Incorporated for a number of months, seems to be bullish on the $87.19 billion market cap company. The stock increased 0.45% or $0.31 during the last trading session, reaching $68.57. About 4.86M shares traded. Gilead Sciences, Inc. (NASDAQ:GILD) has declined 2.61% since June 21, 2018 and is downtrending. It has underperformed by 7.04% the S&P500. Some Historical GILD News: 19/04/2018 – Good news for $GLPG $GILD $ABBV is that FDA sees thrombosis as a unique issue with $INCY $LLY baricitinib and not seen with other JAKi; 06/03/2018 – Searching for HIV cure, Gilead’s new ‘shock and kill’ combo swats back lethal virus in monkeys $GILD; 21/05/2018 – JANSSEN PHARMACEUTICAL – VIIV HEALTHCARE WILL MARKET DOLUTEGRAVIR/RILPIVIRINE IN COUNTRIES IN EUROPEAN UNION & EUROPEAN ECONOMIC AREA; 05/03/2018 – Gilead Sciences: Women in Biktarvy Treatment Arm Maintained High Rates of Virologic Suppression; 30/04/2018 – GILEAD & VERILY REPORT SCIENTIFIC PACT; 02/05/2018 – STAT Plus: Gilead’s ‘trough year’ looking harder to dig out from after miserable first quarter; 13/04/2018 – Gilead Presents Data on Multiple Investigational Regimens for the Treatment of Patients With Nonalcoholic Steatohepatitis (NASH; 30/04/2018 – Gilead and Verily Announce Scientific Collaboration to Identify and Understand Immunological and Molecular Drivers of; 14/05/2018 – Gilead’s Epclusa Falls After 3-Wk Rise, Mavyret Advances: Hep-C; 09/04/2018 – AbbVie’s Mavyret Rises After 2-Wk Fall, Epclusa Advances: Hep-C

Dearborn Partners Llc, which manages about $1.48 billion and $1.50B US Long portfolio, decreased its stake in Abbott Labs (NYSE:ABT) by 4,746 shares to 65,072 shares, valued at $5.20 million in 2019Q1, according to the filing. It also reduced its holding in Occidental Petroleum (NYSE:OXY) by 6,146 shares in the quarter, leaving it with 12,534 shares, and cut its stake in General Dynamics Corp (NYSE:GD).

Investors sentiment increased to 1.02 in Q1 2019. Its up 0.42, from 0.6 in 2018Q4. It increased, as 64 investors sold GILD shares while 421 reduced holdings. 115 funds opened positions while 381 raised stakes. 961.76 million shares or 3.38% less from 995.36 million shares in 2018Q4 were reported. Moreover, Arga Mngmt Ltd Partnership has 0.41% invested in Gilead Sciences, Inc. (NASDAQ:GILD) for 42,104 shares. Aviance Cap Ptnrs Limited Co holds 0.37% or 20,030 shares. Sky Inv Gru Ltd Llc has invested 0.31% in Gilead Sciences, Inc. (NASDAQ:GILD). West Chester Cap Advisors Inc holds 1.18% or 8,714 shares. 49,666 were reported by Smith Salley And Assoc. Tctc Ltd Com, Texas-based fund reported 3,903 shares. Quadrant Mgmt invested 0.66% of its portfolio in Gilead Sciences, Inc. (NASDAQ:GILD). Shamrock Asset Mngmt Ltd Llc reported 6,956 shares. New York-based Clear Harbor Asset Mngmt Limited Liability has invested 0.13% in Gilead Sciences, Inc. (NASDAQ:GILD). 1.87 million are owned by Principal Grp. Vanguard Gp Inc, Pennsylvania-based fund reported 101.35 million shares. Amf Pensionsforsakring has 0.62% invested in Gilead Sciences, Inc. (NASDAQ:GILD) for 962,525 shares. Cognios Cap Ltd Llc accumulated 0.39% or 17,079 shares. Moreover, Mechanics Comml Bank Department has 0.14% invested in Gilead Sciences, Inc. (NASDAQ:GILD) for 9,326 shares. Ontario – Canada-based Highstreet Asset has invested 0.05% in Gilead Sciences, Inc. (NASDAQ:GILD).

More notable recent Gilead Sciences, Inc. (NASDAQ:GILD) news were published by: Benzinga.com which released: “UBS Upgrades Gilead, Sees EPS Upside In 2019 – Benzinga” on April 10, 2019, also 247Wallst.com with their article: “Major Biotechs See a Rising Tide in Short Interest – 24/7 Wall St.” published on May 28, 2019, Nasdaq.com published: “Is Gilead Sciences (GILD) Outperforming Other Medical Stocks This Year? – Nasdaq” on June 12, 2019. More interesting news about Gilead Sciences, Inc. (NASDAQ:GILD) were released by: Nasdaq.com and their article: “Gilead (GILD) Teams Up With Nurix for Cancer and Other Drugs – Nasdaq” published on June 20, 2019 as well as Nasdaq.com‘s news article titled: “Gilead Sciences (GILD) Outpaces Stock Market Gains: What You Should Know – Nasdaq” with publication date: March 13, 2019.

More notable recent International Business Machines Corporation (NYSE:IBM) news were published by: Benzinga.com which released: “The Best Opportunities In Crypto Aren’t Decentralized – Benzinga” on May 29, 2019, also Finance.Yahoo.com with their article: “IBM Watson Advertising and Adweek Create Institute for Brand Marketingâ„¢ – Yahoo Finance” published on June 17, 2019, Benzinga.com published: “Bouncing Back To Blockchain ETFs – Benzinga” on June 16, 2019. More interesting news about International Business Machines Corporation (NYSE:IBM) were released by: Bizjournals.com and their article: “IBM reaches $15 million settlement over false claims allegations – Triangle Business Journal” published on June 14, 2019 as well as Finance.Yahoo.com‘s news article titled: “IBM Expands its Quantum Computing Program to Africa with Wits University – Yahoo Finance” with publication date: June 12, 2019.

Analysts await International Business Machines Corporation (NYSE:IBM) to report earnings on July, 17. They expect $3.06 EPS, down 0.65% or $0.02 from last year’s $3.08 per share. IBM’s profit will be $2.71 billion for 11.34 P/E if the $3.06 EPS becomes a reality. After $2.25 actual EPS reported by International Business Machines Corporation for the previous quarter, Wall Street now forecasts 36.00% EPS growth.

Community Bank, which manages about $495.01M US Long portfolio, upped its stake in 3 Mo Tbill Etf by 6,360 shares to 13,395 shares, valued at $1.23 million in 2019Q1, according to the filing.

Gilead Sciences, Inc. (NASDAQ:GILD) Institutional Positions Chart

Receive News & Ratings Via Email – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings with our FREE daily email newsletter.

.(tagsToTranslate)International Business Machines Corporation(t)International Business Machines Corporation – (NYSE:IBM)(t)NYSE:IBM(t)Stock News(t)13F(t)Insitutional Ownership Change


This is a syndicated post. Read the original post at Source link .